Storage and Handling: A Lab Reference for Peptide Stability

Peptide stability is a controllable variable. The same lot that meets ≥99.0% purity at release can degrade meaningfully over weeks if storage conditions are not maintained — and the degradation is rarely visible without re-analysis. A laboratory using a degraded peptide is running an experiment with a different compound than it intends, which is a methodological problem regardless of the application.

This brief covers the storage parameters that matter, the diluents and conditions that support reconstituted stability, and the documentation chain that supports a stability claim.

Lyophilized peptide is the most stable form. The standard long-term storage condition is −20°C in the original sealed vial, protected from light and moisture. Under those conditions most peptides are stable for two to three years.

Short-term storage at 2–8°C is acceptable for weeks. Repeated cycling between freezer and refrigerator should be avoided because temperature transitions can drive condensation inside the vial — moisture is the principal degradation accelerator for lyophilized peptides.

The standard reconstitution diluent for most research peptides is bacteriostatic water containing 0.9% benzyl alcohol. The benzyl alcohol provides preservation against microbial growth over a multi-week reconstituted shelf life, and the diluent is pharmaceutically standard.

Sterile water for injection is used when the protocol requires no preservative — for example, in cell-culture work where benzyl alcohol toxicity would be a confounder. Reconstituted shelf life is shorter in this case, typically 24–48 hours refrigerated.

Some peptides require an acidic diluent for solubilization — typically 0.1% acetic acid in water — followed by dilution into the working buffer. The product documentation should specify when this is required.

Reconstituted peptide should be stored at 2–8°C, protected from light, and used within the documented stability window for the specific compound. The window varies: BPC-157 in bacteriostatic water is generally stable for 14–28 days; semaglutide and tirzepatide formulations are typically stable for 28–42 days; some less-stable peptides degrade meaningfully within a week.

The compound-specific documentation should be the source of truth for reconstituted stability. Default assumptions extended across compounds is a source of error.

Light exposure accelerates oxidation at sensitive residues — most notably tryptophan, methionine, and cysteine. Amber glass vials and storage in dark conditions reduce this exposure substantially. For peptides containing oxidation-prone residues, light protection is not optional.

Heat accelerates aggregation, deamidation at asparagine and glutamine, and oxidation. Reconstituted peptide left at room temperature for hours rather than minutes should be flagged for re-analysis before use in any quantitative experiment.

Freeze-thaw cycling is the most under-appreciated degradation accelerator. Each cycle creates conditions favorable to aggregation. For peptides that will be used over multiple sessions, the standard practice is to aliquot reconstituted material into single-use volumes, freeze each aliquot once, and thaw on demand. A reconstituted peptide that has been frozen and thawed four times is not the same material it was at first reconstitution.

A stability claim attached to a Certificate of Analysis must be supported by a documented stability study. The study design typically tests the peptide at the claimed storage condition over the claimed shelf life, with periodic re-analysis for purity, identity, and aggregate formation.

For lyophilized stability at −20°C, real-time studies over the claimed shelf life are the gold standard, supplemented by accelerated stability data (elevated temperature) for extrapolation. For reconstituted stability, real-time refrigerated studies over the claimed window are standard.

A vendor claiming long stability without a documented study to support it is making a marketing statement, not a regulatory one. The right response is to request the stability study report.

For a working laboratory, the recommended protocol is: store lyophilized vials at −20°C in original packaging; reconstitute with the documented diluent volume to the documented final concentration; aliquot into single-use working volumes if multiple uses are planned; store working aliquots at 2–8°C protected from light; and document the date of reconstitution on the vial label.

A protocol of this kind preserves the integrity of the material across the reconstituted shelf life and supports reproducibility across experimental sessions.

Reconstituted peptide should be discarded if: the documented shelf life is exceeded; the solution shows visible turbidity, precipitate, or color change; the vial has been left at room temperature for more than a short period; or the peptide has been freeze-thawed beyond the documented cycle limit. Each of these indicates degradation that compromises experimental validity.